Abstract

BackgroundThe Anti Tumour Necrosis Factor (aTNF) therapy in Rheumatics Diseases (RD) had changed the prognosis of theses conditions in the last decade. Unfortunately, aTNF therapy is associated a high-risk rate...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call